Copyright
©2014 Baishideng Publishing Group Co.
World J Hepatol. Apr 27, 2014; 6(4): 160-168
Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.160
Published online Apr 27, 2014. doi: 10.4254/wjh.v6.i4.160
Table 3 Drugs and drug-induced autoimmune liver disease
| Well stablished drugs: |
| Minocycline |
| Nitrofurantoin |
| Oxyphenisatin, alpha-methyl-dopa, clometacin. |
| Emerging drugs: |
| Statins |
| Biologics agents: |
| Infliximab |
| Others: adalimumab, etanercept, efalizumab, ipilimumab |
| Other drugs: |
| Less compelling association (infrequent reports): atomoxetine, diclofenac, fenofibrate, pemoline, phenprocoumon, dihydralazine, tielinic acid, benzarone |
- Citation: Castiella A, Zapata E, Lucena MI, Andrade RJ. Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease. World J Hepatol 2014; 6(4): 160-168
- URL: https://www.wjgnet.com/1948-5182/full/v6/i4/160.htm
- DOI: https://dx.doi.org/10.4254/wjh.v6.i4.160